DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 98

Drugs Pharma Companies Clinical Trials Computational Chemistry 98

Fierce BioTech

SEPTEMBER 30, 2024

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

Pharma Companies 52

Pharma Companies Drug Development Marketing Drugs 52

Fierce BioTech

JULY 25, 2023

How combining datasets from multiple sources can inform and improve commercial strategies Hundreds of rare disease treatments have entered the market over the past decade—thanks largely to a combination of government incentives, strong urging from patient advocacy groups and advances in cell and gene therapies.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

thought leadership

MAY 29, 2023

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. In this blog post, we'll explore some of the key challenges of specialty pharma drug development project management and discuss strategies for overcoming them.

Drug Development 52

Drug Development Pharma Companies Drugs Disease 52

The Pharma Data

NOVEMBER 10, 2020

By employing the services of a CV, the company has access to a fully-managed and outfitted animal research facility that includes supporting services for preclinical rodent research, which gives them complete control over their studies and enables them to keep studies “in-house”. .

Marketing 52

Marketing Science Pharma Companies Research 52

The Pharma Data

NOVEMBER 19, 2020

In the era of “fast-moving products” and digital disruption, pharma companies are battling with customer demand to deliver products to market at increased speed and scale. In this online series, we tackle some of the key challenges affecting manufacturing, data management and R&D in the lab. .

Pharma Companies 52

Pharma Companies Production Marketing Drugs 52

The Pharma Data

AUGUST 5, 2020

Although only two healthcare companies entered the index’s top 20 – Danaher and Medtronic – a number of pharma companies have also seen a rise on the list. This includes Swiss pharma company Roche, which was up 49 places since 2018 and AstraZeneca, which climbed by 20 places.

Pharma Companies 52

Pharma Companies Vaccine Treatment Marketing 52

ACTO

SEPTEMBER 11, 2024

The life sciences industry is actively looking for new ways to leverage AI to bring drugs to market faster to patients waiting in need,” said Parth Khanna, CEO of ACTO. Current solutions are almost exclusively focused on marketing, HCP targeting, workflow automation, and performance insight.

Science 52

Science Pharma Companies Production Marketing 52

The Connected Lab

APRIL 8, 2020

The cost to develop a new prescription medicine that gains market approval has gone up 145% to $2.6 It is reported that every one of the major pharmaceutical companies has announced a partnership with at least one AI-based drug development company, but how is AI being used to facilitate drug development? Nature , vol.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Preclinical and clinical programs at Northern Biologics were acquired by big pharma companies in 2020.

Pharma Companies 52

Pharma Companies Small Molecule Science Disease 52

Drug Patent Watch

JANUARY 9, 2025

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation.

Compliance 52

Compliance Drug Development Therapies Pharma Companies 52

The Pharma Data

AUGUST 20, 2020

It has since expanded nationwide, threatening an important market for many Big Pharma players. . Companies such as AstraZeneca, Sanofi and Eli Lilly have managed to keep business under the aggressive procurement program, but they had to live with major discounts. . It’s not a completely unforeseen shift, though. Source link.

Pharma Companies 52

Pharma Companies International Marketing Drugs 52

H1 Blog

JUNE 7, 2023

Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data will be invaluable in identifying potential contacts for marketing efforts, allowing the Foundation to effectively reach out to physicians who are most likely to be interested in their initiatives.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

H1 Blog

JULY 30, 2024

This crucial inclusion of diverse populations through enrollment accuracy creates a direct correlation to operational efficiency, allowing for a quicker go-to-market process, a reduction in costly mistakes, and a more robust alignment to overall FDA requirements.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose. Save your seat at IDBS’s upcoming webinar.

Virus 52

Virus Vaccine International Immune Response 52

The Pharma Data

JULY 2, 2023

With nearly two decades of experience in sales, marketing and omnichannel excellence, and organizational transformation, Shigeto brings valuable technology-focused asset development and holistic marketing knowledge to Syneos Health. He is a dedicated team builder and is well-versed in people and change management. “As

Pharma Companies 40

Pharma Companies Marketing Therapies 40

The Pharma Data

DECEMBER 4, 2020

The companies have filed a request for Emergency Use Authorization with the US Food and Drug Administration and have submitted the final Conditional Marketing Authorization Application following rolling submissions with the European Medicines Agency and several other regulatory agencies around the world. Save your free seat now.

Vaccine 52

Vaccine Pharma Companies Science Trials 52

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Learn more about LAICA RepAssist by ACTO – the only AI Knowledge Assistant built for pharma field reps!

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

H1 Blog

DECEMBER 11, 2024

While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. Furthermore, as pharma looks to offset future price controls, the prices of new drugs will likely spike.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

JULY 5, 2023

From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Alta Sciences

APRIL 5, 2024

Watch Altasciences in "Flipping the Drug Development Industry on Its Head" A Brief History of the CRO Market Contract Research Organizations (CROs) first entered the pharma world in the 1970s. CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house.

Drug Development 52

Drug Development Pharma Companies Marketing Drugs 52

The Pharma Data

NOVEMBER 16, 2020

A single pill also is cheaper to market and distribute. Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. If it’s more convenient together, why not?”

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

The Pharma Data

NOVEMBER 9, 2020

To learn how your pharma company can progress to the next stage in the digital transformation journey, join Pharma IQ’s one-day masterclass alongside SGK Health as we dive into why authentic human-centric experiences are foundational to a brand’s existence and the successful implementation of a digital marketing strategy.

Vaccine 52

Vaccine Pharma Companies Science Trials 52

The Pharma Data

OCTOBER 20, 2020

MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research. This is where biotechs are essential to take promising discoveries from the research lab into a product that can be tested, approved and taken to market. But now they’ll be choosing the therapies themselves. .

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Vial

MARCH 1, 2024

By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

H1 Blog

NOVEMBER 15, 2023

The compensation provided to KOLs should also be fair-market value for their time and effort, and not an inducement for them to prescribe or recommend specific products. Furthermore, the interactions between life sciences companies and KOLs should be transparent and properly documented.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Altus Drug Development

JUNE 28, 2022

This can drastically reduce the time and money it takes for a repositioned drug to reach the market. By using publicly available data, the researchers concluded that the median cost of bringing a new medicine to the market is $1.3 The restrictively high costs of drug development hinder the efforts of many pharmaceutical companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

JANUARY 31, 2021

During his tenure, Evotec established itself as a leading drug discovery and development company with a particular focus on precision medicine through early adoption of paradigm-shifting technologies such as iPSC-based drug discovery, industrialised multi-omics, and artificial intelligence-driven data analytics throughout the drug discovery process.

Science 52

Science Government Medical Schools International 52

PerkinElmer

FEBRUARY 18, 2021

Dr. Eckelt conducted 23 hour-long, 1:1 interviews over five months in 2020 to gather market insights on how the top 20 Pharma are increasing productivity, efficiency, and speed of drug discovery in the short and long-term. Pharma companies must improve productivity and efficiency amidst rising R&D costs.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

The Premier Consulting Blog

OCTOBER 21, 2024

However, the challenges surrounding confirmatory trials often revolve around delays and the complexities of conducting them once a drug has already hit the market. This decision, communicated in November 2022, delayed the BLA submission as the confirmatory trial needs to reach full enrollment before submission of the marketing application.

Trials 52

Trials FDA Clinical Trials Disease 52

H1 Blog

JUNE 26, 2024

Worldwide Clinical Trials is a leading full-service global CRO (contract research organization) working with biotech and pharma to create customized solutions. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

Predictive Oncology

FEBRUARY 7, 2023

Because pharma companies can’t predict which early-stage drug candidates will succeed, they end up playing a “numbers game,” according to Bush, by advancing multiple compounds. What happens if we are able to provide information to the pharmaceutical company that doubles that [and] one in 10 molecules actually make it?”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Vial

FEBRUARY 19, 2024

By that design, the sum of all parts is designed to solve problems of the current ADCs that are in the market for approval that have quite a bit of a toxicity profile and decreased efficacy potential. That by itself is really important to balance between the commercial, the market conditions, the drug development, and benefits for patients.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

The Pharma Data

NOVEMBER 5, 2020

By a separate press release, the Company has today announced its intention to distribute the BUPI project to the shareholders of Moberg Pharma through a Lex Asea distribution with a subsequent listing on Nasdaq First North Growth Market during the Q1 of 2021. Other expenses for the Company’s operations.

Marketing 40

Marketing Production Regulations Pharma Companies 40

The Pharma Data

OCTOBER 14, 2020

The funds will be used to bring Ori’s innovative manufacturing platform to the market. Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. Ori Biotech – London-based Ori Biotech closed a $30 million Series A financing round.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

Codon

FEBRUARY 13, 2024

To the question of how to turn this from an academic project into a marketable product, he suggests that a complete phage-testing and synthesis system, or a subscription-like service – with access to the phage-matching algorithms and all the necessary genetic data – could eventually attract major investors.

Therapies 131

Therapies Virus DNA Clinical Trials 131